Clinical trial Recruiting at 1 site Interventional Ages 21 to 99

Cardiovascular and Cognitive Health Initiative

Official title: The Cardiovascular-Cognitive Health Initiative

Run by National Heart Centre Singapore · NCT07829380 · Data updated 2026-11-12

This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.

Quick facts

Study typeInterventional
Ages21 Years to 99 Years
SexAll
Enrollment5000 (estimated)
SponsorNational Heart Centre Singapore
Academic / other
Locations4 sites (Singapore and 3 other locations)
StatusRecruiting
StartedAugust 4, 2026
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedSeptember 21, 2026
Trial IDNCT07829380 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21 and older with cardiovascular disease, who can provide informed consent, including those meeting mild cognitive impairment criteria for the sub-study.

Probably not a fit

Individuals without cognitive impairment or who did not experience cognitive improvement with the intervention may not see cognitive benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study examines how memory and thinking are affected in people with cardiovascular disease and whether early detection plus structured interventions can improve cognitive outcomes. It uses a structured approach combining cognitive and cardiovascular care to identify prevalence and profiles of cognitive impairment in this population. An RCT sub-study in mild cognitive impairment will compare cognitive test improvements at 24 weeks between the intervention and usual care arms. Secondary outcomes include changes in memory, processing speed, mental health, frailty, quality of life, and links between cognitive status and cardiovascular treatment plans. The research involves adult participants from three Singaporean hospitals under the National Heart Centre Singapore as lead sponsor.

Why it matters

Potential benefit: If successful, participants may experience improved cognitive function and quality of life through integrated cardiovascular and cognitive care.

How similar studies have gone: Prior work in related areas suggests cognitive and cardiovascular interventions can influence cognitive endpoints, though this specific combination with an RCT in this population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Main Study:

* Age ≥ 21 years.
* Able and willing (or via legally acceptable representative, LAR, where appropriate) to provide informed consent.

RCT Sub-Study (Mild cognitive impairment (MCI) arm):

* Meets main study criteria.
* Mild cognitive impairment defined by: (i) Montreal cognitive assessment (MoCA) \<26 but ≥21; and/or (ii) impairment in at least one domain on standardized neuropsychological testing and/or (iii) MMSE \<28 but ≥24.

Exclusion Criteria:

* Neurodegenerative disorders or major psychiatric illnesses that substantially impair cognition.
* Terminal illness or advanced major organ disease limiting participation with expected survival of less than 1 year.
* Severe depression, anxiety, or stress where participation may be inappropriate.
* Any condition which, in the investigator's opinion, would compromise safety or study integrity.

Note: Pregnant and breast-feeding women may not take part in this study.

Where it's running

  • National Heart Centre Singapore
    Singapore, Singapore
    Recruiting
  • Alexandra Hospital
    Singapore, Singapore
    Not yet recruiting
  • Khoo Teck Puat Hospital
    Singapore, Singapore
    Not yet recruiting
  • Sengkang General Hospital
    Singapore, Singapore
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.